ANGLE (LON:AGL) Trading Down 9.4% – Here’s Why

ANGLE plc (LON:AGL) dropped 9.4% during mid-day trading on Saturday . The company traded as low as GBX 14.22 ($0.18) and last traded at GBX 14.50 ($0.18). Approximately 1,973,299 shares changed hands during trading, an increase of 0% from the average daily volume of 1,970,340 shares. The stock had previously closed at GBX 16 ($0.20).

Analyst Ratings Changes

Separately, Berenberg Bank restated a “buy” rating and set a GBX 40 ($0.50) price target on shares of ANGLE in a research report on Wednesday, January 29th.

ANGLE Stock Down 9.4 %

The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18. The stock has a market capitalization of £46.77 million, a PE ratio of -207.14 and a beta of 0.22. The company has a 50 day moving average price of GBX 11.68 and a 200-day moving average price of GBX 11.19.

ANGLE Company Profile

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.